Financials

  • Market Capitalization 367.58 M
  • Employee 78
  • Founded 2018
  • CEO N/A
  • Website www.centurytx.com
  • Headquarter Delaware, United States
  • FIGI BBG00PM8N5W0
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.11
Price to sales ratio
0.79

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3090
CTNM
Contineum Therapeutics, Inc. - Common stock
17.05 USD-1.16%+0.29%+17.75%+11.66%393.84 M USD
3107
EYPT
EyePoint, Inc. - Common Stock
4.48 USD-3.24%-13.35%-63.19%-62.67%386.23 M USD
3172
FHTX
Foghorn Therapeutics Inc. - Common Stock
6.00 USD-3.54%-16.90%+26.58%+47.06%356.31 M USD
3173
LYEL
Lyell Immunopharma, Inc. - Common Stock
14.53 USD-0.55%-5.03%+11.94%-39.93%356.06 M USD

Frequently asked questions about Century Therapeutics, Inc. Common Stock

What is the Century Therapeutics, Inc. Common Stock stock price today?

The current price of Century Therapeutics, Inc. Common Stock (IPSC) is 2.03. Over the past 24 hours, the stock has changed by -8.97%. Follow the IPSC chart for real-time price dynamics.

What is the stock ticker of Century Therapeutics, Inc. Common Stock?

Century Therapeutics, Inc. Common Stock trades under the ticker IPSC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Century Therapeutics, Inc. Common Stock stock going up?

IPSC has changed by -2.40% over the last week, -0.49% over the last month, and +314.29% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Century Therapeutics, Inc. Common Stock?

Century Therapeutics, Inc. Common Stock currently has a market capitalization of 367.58 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Century Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Century Therapeutics, Inc. Common Stock reported earnings of -0.17 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Century Therapeutics, Inc. Common Stock net income for the last quarter?

Century Therapeutics, Inc. Common Stock reported net income of -34.55 M for the last quarter. The previous quarter showed -21.64 M, which means net income changed by -59.62%.

How many employees does Century Therapeutics, Inc. Common Stock have?

As of the latest available data, Century Therapeutics, Inc. Common Stock has 78 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Century Therapeutics, Inc. Common Stock stock?

You can buy Century Therapeutics, Inc. Common Stock (IPSC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Century Therapeutics, Inc. Common Stock stock?

Investing in Century Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IPSC chart and related analysis on metatrader.com as part of your research.

News